Intralymphatic immunotherapy with one or two allergens renders similar clinical response in patients with allergic rhinitis due to birch and grass pollen.

Publication Year: 2022

DOI:
10.1111/cea.14138

PMCID:
PMC9325375

PMID:
35332591

Journal Information

Full Title: Clin Exp Allergy

Abbreviation: Clin Exp Allergy

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST LA has received honoraria as a speaker and/or adviser from AstraZeneca, Meda, Takeda, Teva, Boehringer Ingelheim, MSD, Sanofi, GlaxsSmithKleine, Novartis and Airsonett. JB has received honoraria as a speaker from ALK. PN has received honoraria as a speaker and/or adviser from AstraZeneca, CSL Behring and Takeda."

Evidence found in paper:

"Funding information"

Evidence found in paper:

"Clinical Trial Registration: EudraCT (2013‐004726‐28)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025